Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease.
Gupta
S
S
Department of Cardiological Sciences, St George's Hospital Medical School, London, UK. sgupta@sghms.ac.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae / Q000472:pathogenicity*; D003327:Coronary Disease / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology*; D008297:Male; D009000:Monocytes / Q000276:immunology*; D010865:Pilot Projects; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D000900:Anti-Bacterial Agents; D017963:Azithromycin